THE TEAM

THE TEAM

Stacks Image 1275
TODD BIXBY
CO-FOUNDER & CHIEF EXECUTIVE OFFICER
Biotechnology developer, technology analyst, business and corporate strategist, and public health innovator with over 20 years experience advancing biotechnologies to promote healthier communities and environments. Worked to develop and deploy advanced technologies for human health, environmental health, biosecurity, biodefense, sustainable food production, consumer products, and conservation.

Developed groundbreaking FDA-cleared products including current molecular tests for safety screening of the U.S. blood supply (HIV, HCV, HBV, West Nile virus) and launched the APTIMA molecular diagnostics platform with the first FDA-cleared combined chlamydia and gonorrhea molecular test. Participated in the deployment of pioneering mobile HIV / CD4 diagnostics for low resource settings in Sub-Saharan Africa. Deep experience advancing several synthetic biology and genetic engineering technologies, as well as first-in-class gene-edited and genetically engineered products regulated by FDA, USDA, and EPA. Dedicated to developing medicines, biothreat detection systems, and environmental interventions aimed at improving global public health and biosecurity.
Stacks Image 1289
TODD BIXBY
CO-FOUNDER &
CHIEF EXECUTIVE OFFICER
Biotechnology developer, technology analyst, business and corporate strategist, and public health innovator with over 20 years experience advancing biotechnologies to promote healthier communities and environments. Worked to develop and deploy advanced technologies for human health, environmental health, biosecurity, biodefense, sustainable food production, consumer products, and conservation.

Developed groundbreaking FDA-cleared products including current molecular tests for safety screening of the U.S. blood supply (HIV, HCV, HBV, West Nile virus) and launched the APTIMA molecular diagnostics platform with the first FDA-cleared combined chlamydia and gonorrhea molecular test. Participated in the deployment of pioneering mobile HIV / CD4 diagnostics for low resource settings in Sub-Saharan Africa. Deep experience advancing several synthetic biology and genetic engineering technologies, as well as first-in-class gene-edited and genetically engineered products regulated by FDA, USDA, and EPA. Dedicated to developing medicines, biothreat detection systems, and environmental interventions aimed at improving global public health and biosecurity.

Stacks Image 1307
RICHARD EINSTEIN, PHD
FOUNDER & CHIEF SCIENCE OFFICER
Highly experienced executive in managing a diverse group of stakeholders and teams, including C-level executives, middle managers, investors, clinicians, academicians, and patient advocates, required for the execution of complex technical platforms, the generation of first product instance, and meaningful patient outcomes.

Over 30 years experience developing molecular technology platforms from concept to data validation in a variety of therapeutic areas and technologies including genomics, gene and cell therapies.
Stacks Image 1317
RICHARD EINSTEIN, PHD
FOUNDER &
CHIEF SCIENCE OFFICER
Highly experienced executive in managing a diverse group of stakeholders and teams, including C-level executives, middle managers, investors, clinicians, academicians, and patient advocates, required for the execution of complex technical platforms, the generation of first product instance, and meaningful patient outcomes.

Over 30 years experience developing molecular technology platforms from concept to data validation in a variety of therapeutic areas and technologies including genomics, gene and cell therapies.

Stacks Image 1328
GAVIN HANEY
CO-FOUNDER & ADVISOR, COMMERCIAL STRATEGY
More than 20 years of successful results in biotechnology sales and marketing across molecular diagnostics for infectious disease, prenatal, ophthalmology and oncology.

Deep experience in a broad array of commercial roles of increasing responsibility including strategic partnerships, product development, clinical validation, reimbursement strategy, product launches, KOL engagement, medical education programs, sales operations and leading high performing sales and marketing teams.
Stacks Image 1337
GAVIN HANEY
CO-FOUNDER & ADVISOR,
COMMERCIAL STRATEGY
More than 20 years of successful results in biotechnology sales and marketing across molecular diagnostics for infectious disease, prenatal, ophthalmology and oncology.

Deep experience in a broad array of commercial roles of increasing responsibility including strategic partnerships, product development, clinical validation, reimbursement strategy, product launches, KOL engagement, medical education programs, sales operations and leading high performing sales and marketing teams.

Stacks Image 1349
DAVID SIMMS
CO-FOUNDER & ADVISOR, BUSINESS ANALYTICS
A business development leader with extensive experience in emerging technology projects, market analyses, and capital investment activities. His work experience includes creating business cases for environmental biotech and cleantech ventures, supporting multiple Department of Defense contracts, and working at the Centers for Disease Control and Prevention (CDC). He holds an MS in Biotechnology and an MBA from Johns Hopkins University.
Stacks Image 1359
DAVID SIMMS
CO-FOUNDER & ADVISOR,
BUSINESS ANALYTICS
A business development leader with extensive experience in emerging technology projects, market analyses, and capital investment activities. His work experience includes creating business cases for environmental biotech and cleantech ventures, supporting multiple Department of Defense contracts, and working at the Centers for Disease Control and Prevention (CDC). He holds an MS in Biotechnology and an MBA from Johns Hopkins University.
Stacks Image 1234

WHY US?

OUR PASSION reflects our commitment to society to accelerate the development of transformative technologies for healthier people and a healthier planet.

OUR COMMITMENT to development of the best solutions for health is realized in the mindful insight and guidance we provide in collaboration with our partners and investors.

OUR EXPERIENCE driving R&D and commercial operations is extensive. Decades of industry experience informs our approach to investing in cutting edge genomic solutions to solve challenging problems and improve health outcomes.

OUR TEAM understands how to manage the interactions required to advance technologies from concept to commercial success. We focus on connecting the technology and resources necessary to advance from pre-seed to seed-funded product prototype stages through series raises for product development and commercial launch.

MANAGEMENT EXPERTISE

Stacks Image 1527
Proven track record of commercial success with over 80 years of combined experience with diagnostic and therapeutic development, as well as, first-in-class product launches
Obtained FDA approvals for molecular diagnostics (PMA, BLA, 510k, EUA), as well as, development of numerous first-in-class biotechnologies regulated by EPA and USDA
Pioneered novel companion and molecular diagnostics, in addition to applications employing genetic and genome engineering for precision medicine, public health interventions and food technologies
Experts at design and development to meet FDA, CE and ISO 9001 guidelines through research feasibility, clinical validation, manufacturing scale up and commercial product launch
Developed and validated commercial business cases for technology-based investment opportunities for biotechnology companies and the Department of Defense (DoD)
Established relationships with leaders in industry, academia, and government, in addition to subject matter experts, physician key opinion leaders and other influencers
Proven track record of commercial success with over 80 years of combined experience with diagnostic and therapeutic development, as well as, first-in-class product launches
Obtained FDA approvals for molecular diagnostics (PMA, BLA, 510k, EUA), as well as, development of numerous first-in-class biotechnologies regulated by EPA and USDA
Pioneered novel companion and molecular diagnostics, in addition to applications employing genetic and genome engineering for precision medicine, public health interventions and food technologies
Experts at design and development to meet FDA, CE and ISO 9001 guidelines through research feasibility, clinical validation, manufacturing scale up and commercial product launch
Developed and validated commercial business cases for technology-based investment opportunities for biotechnology companies and the Department of Defense (DoD)
Established relationships with leaders in industry, academia, and government, in addition to subject matter experts, physician key opinion leaders and other influencers
Stacks Image 1393
Regarding collaboration opportunities please contact info@planetary-genetics.com.
Learn more about investment opportunities here.
Stacks Image 1236